FDA Approval of Pfizer’s Prevnar Vaccine Delayed Until Jan 2012
According to Pfizer Inc., the US regulatory approval of its pneumococcal vaccine, Prevnar 13, for use in adults will take
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine